He is involved with a lot of companies, as noted below. Thoughts???
Jim
Mr. Uri Ben-Or, also known as Kles , CPA, MBA, serves as the Chief Executive Officer of CFO Direct Ltd. Mr. Ben-Or serves as the Chief Financial Officer at Glycominds Ltd., Widmed Ltd., Globalicom-Trade Ltd., Topsin Medical Inc., Solegreen Ltd. (Alternative Name: Procognia Israel Ltd.).
He has been the Chief Financial Officer of Cannabics Pharmaceuticals Inc. since November 05, 2016. He has been the Chief Financial Officer of My Size, Inc. since September 20, 2010.
He provides his services to BiondVax through CFO Direct, a company which he founded and serves as its Chief Executive Officer. He served as the Chief Financial Officer of NextNine Ltd.
He has been the Chief Financial Officer of BiondVax Pharmaceuticals Ltd. since 2007 and served as its Vice President of Finance.
Mr. Ben-Or has over a 20 years of broad experience in corporate finance, accounting, M&A transactions, IPO's and operations. He served as Chief Financial Officer of Therapix Biosciences Ltd. until January 6, 2016.
He served as Chief Financial Officer at InterCure Ltd. since 2013. He served as the Chief Financial Officer of D. Medical Industries Ltd. since February 6, 2013. He served as the Chief Financial Officer of Hadasit Bio-Holdings, Ltd. (Alternative Name: HBL-Hadasit Bio-Holdings Ltd.) and WideMed Ltd. Prior to founding CFODirect, he served as a Vice President of Finance for Glycominds Ltd.
He served as Director of Finance and Administration at Glycominds Ltd. and as the Chief Financial Officer of a spin-off from Telrad Networks, where he led all the corporate finance activities, fund raising and legal aspects.
He served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PricewaterhouseCoopers. He is a Certified Public Accountant.
Mr. Ben-Or holds a BA degree in Business Administration from the College of Administration and an MBA degree from the Bar Ilan University.
Recent CNBX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/15/2024 02:58:24 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:27:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 03:13:35 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM